(SCHD) Schwab U.S. Dividend Equity - Overview
High-Dividend, US-Equity, Consistent-Payout, Fundamentally-Strong
Dividends
| Dividend Yield | 3.85% |
| Yield on Cost 5y | 5.83% |
| Yield CAGR 5y | -17.40% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.5% |
| Relative Tail Risk | -2.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.36 |
| Alpha | -2.83 |
| Character TTM | |
|---|---|
| Beta | 0.619 |
| Beta Downside | 0.706 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.13% |
| CAGR/Max DD | 0.51 |
Description: SCHD Schwab U.S. Dividend Equity January 29, 2026
Schwab U.S. Dividend Equity ETF (SCHD) tracks an index of high-yielding U.S. stocks that have demonstrated consistent dividend payments and above-average fundamental strength, as measured by financial ratios. The fund commits at least 90 % of its net assets to these qualifying equities, positioning it squarely in the large-value segment.
As of the most recent quarterly filing (Q4 2025), SCHD holds roughly $27 billion in assets, charges a low 0.06 % expense ratio, and delivers a distribution yield of about 3.7 %. Its 12-month total return sits near 8.9 %, with top holdings including Microsoft, Apple, Johnson & Johnson, JPMorgan Chase, and Procter & Gamble. Sector exposure is weighted toward technology (≈30 %), consumer staples (≈20 %) and health care (≈15 %). Key drivers of performance are the Federal Reserve’s interest-rate stance-higher rates can pressure dividend-focused equities-and the overall health of corporate earnings, which underpins dividend sustainability.
If you want a data-rich, quantitative view of SCHD’s valuation and dividend metrics, a quick look at ValueRay’s screening tools can be a useful next step.
What is the price of SCHD shares?
Over the past week, the price has changed by +0.51%, over one month by +6.08%, over three months by +9.63% and over the past year by +8.47%.
Is SCHD a buy, sell or hold?
What are the forecasts/targets for the SCHD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32 | 9% |
SCHD Fundamental Data Overview January 29, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 76.50b USD (76.50b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 76.50b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 76.50b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.18% (E(76.50b)/V(76.50b) * Re(8.18%) + (debt-free company))
Discount Rate = 8.18% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)